欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DK/H/2619/001
药品名称Dexmedetomidine "Ever Pharma"
活性成分
    • dexmedetomidine hydrochloride 100.0 mcg/ml
剂型Concentrate for solution for infusion
上市许可持有人Ever Valinject GmbH Oberburgau 3 Unterach am Attersee Austria
参考成员国 - 产品名称Denmark (DK)
Dexmedetomidin Ever Pharma
互认成员国 - 产品名称
    • Germany (DE)
      Dexmedetomidin EVER Valinject 100 Mikrogramm/ml Konzentrat zur Herstellung einer Infusionslösung
    • Belgium (BE)
      Dexmedetomidine EVER Pharma 100 microgram/ml concentraat voor oplossing voor infusie
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Dexmedetomidin EVER Pharma 100 Mikrogramm/ml Konzentrat zur Herstellung einer Infusionslösung
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
      Dexmedetomidine EVER Pharma
    • Poland (PL)
      Dexmedetomidine EVER Pharma
    • Czechia (CZ)
      DEXMEDETOMIDINE EVER PHARMA 100 mikrogramů/ml koncentrát pro infuzní roztok
    • Slovakia (SK)
    • France (FR)
    • Portugal (PT)
    • Hungary (HU)
      DEXMEDETOMIDIN EVER PHARMA 100 mikrogramm/ml koncentrátum oldatos infúzióhoz
    • Slovenia (SI)
    • Croatia (HR)
许可日期2017/09/21
最近更新日期2023/09/25
药物ATC编码
    • N05CM18 dexmedetomidine
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase